Campuzano MG

Language: Spanish
References: 10
Page: 509-510
PDF size: 117.89 Kb.

Text Extraction

No abstract

REFERENCES

1. Piñeros M, Ferlay J, Murillo R. Cancer incidence estimates at the national and district levels in Colombia. Salud Publica Mex 2006;48:455-465.

2. Choconta-Piraquive LA, Alvis-Guzman N, De la Hoz-Restrepo F. How protective is cervical cancer screening against cervical cancer mortality in developing countries? The Colombian case. BMC Health Serv Res 2010;10:270.

3. WHO/ICO Information Centre on HPV and Cervical Cancer (HPV Information Centre). Human Papillomavirus and Related Cancers in Colombia. Summary Report 2010. Fecha de acceso diciembre 22 de 2010, disponible en www. who. int/ hpvcentre.

4. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189:12-19.

5. Muñoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003;348:518-527.

6. Gravitt PE, Jamshidi R. Diagnosis and management of oncogenic cervical human papillomavirus infection. Infect Dis Clin North Am 2005;19:439-458.

7. Gutierrez-Xicotencatl L, Plett-Torres T, Madrid- Gonzalez CL, Madrid-Marina V. Molecular diagnosis of human papillomavirus in the development of cervical cancer. Salud Publica Mex 2009;51 Suppl 3:S479-488.

8. Burger EA, Kornor H, Klemp M, Lauvrak V, Kristiansen IS. HPV mRNA tests for the detection of cervical intraepithelial neoplasia: A systematic review. Gynecol Oncol 2010.

9. Halfon P, Benmoura D, Agostini A, Khiri H, Martineau A, Penaranda G, et al. Relevance of HPV mRNA detection in a population of ASCUS plus women using the NucliSENS EasyQ HPV assay. J Clin Virol 2010;47:177-181.

10. Toro-Montoya AI, Piedrahita-Ochoa CA, Gallego- Noreña G. Tamización y prevención del cáncer cervical causado por papilomavirus. Medicina & Laboratorio 2010;16:511-546.